[Radioimmunologic determination of growth factors. II. Comparative development of methods for the determination of hematopoietic growth factors]. / Radioimunolosko odredivanje faktora rasta. II. Uporedni razvoj metoda za odredivanje hematopoeznih faktora rasta.

On the basis of our long-term experience, presented are the current clinically useful methods for determining erythropoietin, the granulocytopoiesis growth factor and thrombocytopoietin with the results in their use. Facts are shown, concerning the long-used method of determining erythropoietin through the use of the biological test on polycythemic mice. In our conditions, mice treated with physiological solution (negative controls) have a Fe-59 incorporation below 0.5% of the given dose, while 0.2 units of the international erythropoietin standard (positive control) increases that incorporation to 3.0%. Also presented, are results of determining erythropoietin by means of the newest immunometric method which has shown exceptional features: the whole procedure, including necessary rinsings, lasts about six hours, and it is possible, in the course of one work day, to all at once precisely determine the erythropoietin concentration in 80 samples of human serum. This fact, as well as the outstanding sensitivity of the method which is about 2 mJ/ml (that is 50 times the sensitivity of the biological test) has as a result, the wide introduction of erythropoietin determination in the clinical use of today and the definition of its clinical importance. The measurement range of the method is from 2-200 J/L which can be extended further by specimen dilution. It is especially important that duplicate measurements at one point of the curve almost coincide, which indicates great method precision. The lowest measured concentration in our series amounted to 0 J/L and the greatest to greater than 250 J/L. Elevated values were found in 17 of the 114 serums.(ABSTRACT TRUNCATED AT 250 WORDS)

[Determination of 17-alpha-hydroxyprogesterone in the diagnosis of congenital adrenal hyperplasia]. / Odredivanje 17-alfa-hidroksiprogesterona u dijagnostici kongenitalne adrenalne hiperplazije.

On the basis of data from literature and by the use of commercial accessories radioimmunologic method of the determination od 17-alpha-hydroxiprogesteron (17-OHPG) serum level was determined in two variants: a) addition to the previous extraction, b) without extraction. It was initiated in the clinical work for diagnostic of congenital adrenal hyperplasia (CAH) induced by the enzymatic block of C21-hydroxilasis. 17-OHPG level was determined in a group of 15 children aged 2-12 of both sexes not suffering from endocrinous diseases. Mean values od X = 3.2 +/- 2.7 nmol/L and X = 4.3 +/- 3.3 nmol/L were obtained under a) and b), respectively. Also, 17-OHPG concentration was determined in 15 women without any endocrinous diseases by the method under b) and mean value of X = 2.5 +/- 1.7 nmol/L was obtained. 17-OHPG level was determined in a group of 7 children in whom CAH had been verified 3 days after the interruption of the substitutional therapy. According to the results of the investigation it was pointed out that there was a marked increase in 17-OHPG serum level (particularly by the use of b) method) which was far outside the range of reference values. In cases both with 17-OHPG determination and the daily pregnantriol excretion it was noticed that the increase in 17-OHPG was almost always accompanied by the increase in pregnantriol as well. Cortisolemia ranged from normal up to very lowered values.(ABSTRACT TRUNCATED AT 250 WORDS)

[Radioimmunologic determination of growth factors. I. Determination of somatomedin C]. / Radioimunolosko odredivanje faktora rasta. I. Odredivanje somatomedina C.

The authors' first experience in the determination of plasma somatomedin C concentration by the radioimmunologic method without extraction was put forward. The method itself was checked up through the routine indicators and the range of normal limits was established by the determination of this concentration in the plasma of 15 healthy persons. Values of plasma and serum determination greatly differentiated. By the determination of somatomedin C concentration and growth hormone during the insulin test in 8 persons it was shown that somatomedin C concentration did not change by the abrupt and short changes in growth hormone concentration. A good correlation was made by the comparison of sometomedin C and growth hormone basal concentration in 16 samples whereby the regulatory role of growth hormone in somatomedin C excretion was confirmed. In conclusion, radioimmunologic determination of sometomedin C in diagnostics and the therapy of growth disturbance was emphasized.